Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Preliminary report of a phase I trial of concurrent Taxol and BID radiotherapy in patients with advanced stage squamous cell carcinoma of the head and neck

Preliminary report of a phase I trial of concurrent Taxol and BID radiotherapy in patients with advanced stage squamous cell carcinoma of the head and neck. ASCO. 1999; 403 (#1556).


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.